Showing 2361-2370 of 2656 results for "".
- Iveric Bio Announces Positive Zimura 18 Month Data Supporting the 12 Month Efficacy Findings for GA Secondary to AMDhttps://modernod.com/news/iveric-bio-announces-positive-zimura-18-month-data-supporting-the-12-month-efficacy-findings/2479517/Iveric bio announced positive 18 month results from the company’s first phase 3 clinical trial for Zimura (avacincaptad pegol), a novel complement C5 inhibitor, for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD). The 18 month data support
- ProQR Announces Expert Perspectives Conference Call Serieshttps://modernod.com/news/proqr-announces-expert-perspectives-conference-call-series/2479518/ProQR Therapeutics, a company dedicated to changing lives through the creation of transformative RNA therapies for severe genetic rare diseases, announced that it will launch a series of Expert Perspectives calls to provide an in-depth review of topics related to the company’s pipeline and
- Johnson & Johnson Announces Acceleration of its COVID-19 Vaccine Candidatehttps://modernod.com/news/johnson-johnson-announces-acceleration-of-its-covid-19-vaccine-candidate/2477889/Johnson & Johnson announced that through its Janssen Pharmaceutical Companies division that it has accelerated the initiation of the phase 1/2a first-in-human clinical trial of its investigational SARS-CoV-2 vaccine, Ad26.COV2-S, recombinant. Initially scheduled to begin in September, the tri
- Oxford Biomedica Snags Manufacturing Equipment to Ramp Up Production of COVID-19 Vaccinehttps://modernod.com/news/oxford-biomedica-snags-manufacturing-equipment-to-ramp-up-production-of-covid-19-vaccine/2477880/In the race for a COVID-19 vaccine, the University of Oxford has stormed to an early lead with the commercial manufacturing support of British drugmaker AstraZeneca. Now, in an effort to scale up capacity for global demand, one of AstraZeneca’s manufacturing partners has struck a deal for n
- Coronavirus Testing Machines Are Latest Bottleneck In Troubled Supply Chainhttps://modernod.com/news/coronavirus-testing-machines-are-latest-bottleneck-in-troubled-supply-chain/2477835/Coronavirus testing in the U.S. has run into a number of snags, from a lack of nasal swabs to not enough chemicals needed to run the tests. Now there’s a new bottleneck emerging: A shortage of the machines that process the tests and give results, according to an NPR
- Caren Mason, CEO of Starr Surgical, Named to Top 50 Healthcare Technology CEOs Of 2020https://modernod.com/news/caren-mason-ceo-of-starr-surgical-named-to-top-50-healthcare-technology-ceos-of-2020/2477827/The Healthcare Technology Report announced The Top 50 Healthcare Technology CEOs of 2020. Data on each CEO’s professional background was gathered and they were assessed across several key areas, including breadth of leadership experience in the healthcare technology industry, level of exper
- Politics Around Hydroxychloroquine Hamper Sciencehttps://modernod.com/news/politics-around-hydroxychloroquine-hamper-science/2477807/Publicity around the drug hydroxychloroquine spiked this week when President Donald Trump revealed that he’s taking it to prevent COVID-19. All the attention on the drug in recent months is increasingly spilling into science, and making it harder for some researchers to actually study wheth
- NIH to Test Hydroxychloroquine, Azithromycin Combination as Potential COVID-19 Treatmenthttps://modernod.com/news/nih-to-test-hydroxychloroquine-azithromycin-combination-as-potential-covid-19-treatment/2477775/The US National Institutes of Health (NIH) said Thursday that it is launching a clinical trial evaluating the combination of hydroxychloroquine plus azithromycin to treat patients with mild-to-moderate COVID-19 in the US. Anthony Fauci, director of the NIH’s National Institute of Allergy an
- Prevent Blindness Unveils New Brand Identity, Logo and Websitehttps://modernod.com/news/prevent-blindness-unveils-new-brand-identity-logo-and-website/2477772/Prevent Blindness announced the launch of its new brand identity, logo, and website. The launch coincides with the organization’s new “Be a Visionary” campaign: a call to action to join in the sight-saving efforts of Prevent Blindness. The new identity is designed to refl
- Trump to Name Former GlaxoSmithKline Executive to Head “Warp Speed” Coronavirus Vaccine Effort: Reportshttps://modernod.com/news/trump-to-name-former-glaxosmithkline-executive-to-head-warp-speed-coronavirus-vaccine-effort-reports/2477765/According to White House officials cited in several reports Wednesday, President Donald Trump is expected to appoint Moncef Slaoui, the former chairman of GlaxoSmithKline’s vaccines division, as chief adviser of Operation Warp Speed, an initiative aimed at speeding up the search for a coron